Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.36 HKD
Change Today +0.04 / 1.72%
Volume 2.8M
As of 4:01 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for china grand pharmaceutical a (512)

Year over year, China Grand Pharmaceutical and Healthcare Holdings Ltd. has been able to grow revenues from $2.7B HKD to $3.1B HKD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 66.65% to 61.77%. This was a driver that led to a bottom line growth from $99.7M HKD to $175.2M HKD.
View Income Statement In U.S. Dollar
Currency in
Millions of Hong Kong Dollars
As of:Dec 31
2011
Reclassified
HKD
Dec 31
2012
HKD
Dec 31
2013
Reclassified
HKD
Dec 31
2014
HKD
4 Year
Trend
Revenues1,647.62,059.32,658.33,122.1
TOTAL REVENUES1,647.62,059.32,658.33,122.1
Cost of Goods Sold1,132.51,414.11,771.81,928.5
GROSS PROFIT515.1645.2886.51,193.6
Selling General & Admin Expenses, Total467.6577.3772.1980.6
Other Operating Expenses-57.0-79.4-75.1-87.0
OTHER OPERATING EXPENSES, TOTAL410.6497.9697.1893.6
OPERATING INCOME104.5147.3189.5300.1
Interest Expense-26.4-41.8-77.6-114.1
Interest and Investment Income7.09.014.115.4
NET INTEREST EXPENSE-19.4-32.8-63.6-98.7
Income (Loss) on Equity Investments0.50.00.30.6
EBT, EXCLUDING UNUSUAL ITEMS85.7114.5126.2202.0
Merger & Restructuring Charges-0.2------
Gain (Loss) on Sale of Investments----6.71.9
Gain (Loss) on Sale of Assets4.01.0-0.6-0.9
Other Unusual Items, Total10.1------
Insurance Settlements10.1------
EBT, INCLUDING UNUSUAL ITEMS99.5115.5132.3202.9
Income Tax Expense12.810.827.027.2
Minority Interest in Earnings-32.4-37.4-5.6-0.5
Earnings from Continuing Operations86.7104.7105.3175.7
NET INCOME54.267.399.7175.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS54.267.399.7175.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS54.267.399.7175.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
512:HK $2.36 HKD +0.04

512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY77.28 CNY -1.50
View Industry Companies
 

Industry Analysis

512

Industry Average

Valuation 512 Industry Range
Price/Earnings 26.7x
Price/Sales 1.5x
Price/Book 4.1x
Price/Cash Flow 26.0x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA GRAND PHARMACEUTICAL A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.